Skip to main content
. 2021 Jan 15;13(2):299. doi: 10.3390/cancers13020299

Figure 23.

Figure 23

RAFT-c(RGDfk)4-Cry-55gly and antiproliferative activity against U87 human glioblastoma, M21 and M21-L human melanoma cell lines.